Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); HR 4899 (Supplemental Appropriations: Section 4201-4206)
Protecting Consumer Access to Generic Drugs Act of 2009
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 1706 (Protecting Consumer Access to Generic Drugs Act), S. 369 (Preserve Access to Affordable Drugs Act, H.R. 4899 (Suuplemental Appropriations: Sections 4201-4206). Drug disposal legislation, Food safety Bill and REMS.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2011 · first_quarter · Q1
Authorized generics, drug safety legislation, legislation with potential to affect generic drugs
Patent settlements and patent reform legislation
Source: Senate LDA
Protecting Consumer Access to Generic Drugs Act of 2009
Client: VIATRIS INC · Firm: VIATRIS INC.
HR 1706 Protecting Consumer Access to Generic Drugs Act S 369 Preserve Access to Affordable Generics Act; HR 4899 (sections 4201-4206) regarding drug safety proposal,drug disposal legislation, authorized generics, generic biologics, FDA.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 573, Bill to prohibit authorized generics during period of exclusivity; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 573, Bill to prohibit authorized generics during period of exclusivity; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101
H.R. 573, Bill to prohibit authorized generics during period of exclusivity; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101
H.R. 1706 (Protecting Consumer Access to Generic Drugs Act), S. 369 (Preserve Access to Affordable Drugs Act, H.R. 4899 (Suuplemental Appropriations: Sections 4201-4206). Drug disposal legislation, Food safety Bill and REMS.
HR 1706 Protecting Consumer Access to Generic Drugs Act S 369 Preserve Access to Affordable Generics Act; HR 4899 (sections 4201-4206) regarding drug safety proposal,drug disposal legislation, authorized generics, generic biologics, FDA.
H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); HR 4899 (Supplemental Appropriations: Section 4201-4206)
H.R. 573, Bill to prohibit authorized generics during period of exclusivity; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101
H.R. 573, Bill to prohibit authorized generics during period of exclusivity; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101
Community-Based Mental Health Infrastructure Improvements Act
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); HR 4899 (Supplemental Appropriations: Section 4201-4206)
Community-Based Mental Health Infrastructure Improvements Act
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 1706 (Protecting Consumer Access to Generic Drugs Act), S. 369 (Preserve Access to Affordable Drugs Act, H.R. 4899 (Suuplemental Appropriations: Sections 4201-4206). Drug disposal legislation, Food safety Bill and REMS.
Community-Based Mental Health Infrastructure Improvements Act
Client: VIATRIS INC · Firm: VIATRIS INC.
HR 1706 Protecting Consumer Access to Generic Drugs Act S 369 Preserve Access to Affordable Generics Act; HR 4899 (sections 4201-4206) regarding drug safety proposal,drug disposal legislation, authorized generics, generic biologics, FDA.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 573- Bill to prohibit Authorized Generics during exclusivity period, H.R. 1706 - Protecting consumer access to generics drug act, H.R 1427 - Promoting innovation and access to life-saving medicine act, S.369 - Preserve access to affordable generics act.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 573, Bill to prohibit authorized generics during period of exclusivity; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101
Protecting Consumer Access to Generic Drugs Act of 2009
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 573- Bill to prohibit Authorized Generics during exclusivity period, H.R. 1706 - Protecting consumer access to generics drug act, H.R 1427 - Promoting innovation and access to life-saving medicine act, S.369 - Preserve access to affordable generics act.
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 573- Bill to prohibit Authorized Generics during exclusivity period, H.R. 1706 - Protecting consumer access to generics drug act, H.R 1427 - Promoting innovation and access to life-saving medicine act, S.369 - Preserve access to affordable generics act.
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 573, Bill to prohibit authorized generics during period of exclusivity; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101
H.R. 573, Bill to prohibit authorized generics during period of exclusivity; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101
H.R. 573- Bill to prohibit Authorized Generics during exclusivity period, H.R. 1706 - Protecting consumer access to generics drug act, H.R 1427 - Promoting innovation and access to life-saving medicine act, S.369 - Preserve access to affordable generics act.
H.R. 573, Bill to prohibit authorized generics during period of exclusivity; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101
H.R. 573, Bill to prohibit authorized generics during period of exclusivity; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree. Authorized Generics
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree. Authorized Generics
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree.
HR 2900/S 1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree.
HR2900/S1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act.
HR2900/S1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act.
HR2900/S1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics.
S.1145/HR1908 Patent Reform. S316/HR1432 Patent Settlements.
S. 1145 / HR 1908 Patent Reform. S316/HR 1432 Patent Settlements.
S.1145/HR1908 Patent Reform. S316/HR1432 Patent Settlements.
S. 1145 / HR 1908 Patent Reform. S316/HR 1432 Patent Settlements.
Food and Drug Administration Amendments Act of 2007
Client: VIATRIS INC · Firm: VIATRIS INC.
HR2900/S1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics.
Food and Drug Administration Amendments Act of 2007
Client: VIATRIS INC · Firm: VIATRIS INC.
HR2900/S1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act.
Food and Drug Administration Amendments Act of 2007
Client: VIATRIS INC · Firm: VIATRIS INC.
HR2900/S1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act.
Food and Drug Administration Amendments Act of 2007
Client: VIATRIS INC · Firm: VIATRIS INC.
HR 2900/S 1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics.
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5501/S.2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/AIDS drug treatment.
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5501/S.2731, tom Lantos and Henry J. Hyde United States Global Leasership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/Aids drug treatment.
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5501/S.2731, tom Lantos and Henry J. Hyde United States Global Leasership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/Aids drug treatment.
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5501/S.2731, tom Lantos and Henry J. Hyde United States Global Leasership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/Aids drug treatment.
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5501/S.2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/AIDS drug treatment.
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5501/S.2731, tom Lantos and Henry J. Hyde United States Global Leasership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/Aids drug treatment.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree. Authorized Generics
HR2900/S1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act.
HR2900/S1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree.
HR 2900/S 1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics.
HR2900/S1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree. Authorized Generics
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree. Authorized Generics
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree. Authorized Generics
Medicare Improvements for Patients and Providers Act of 2008
Client: VIATRIS INC · Firm: VIATRIS INC.
S3101/HR6331 Medicare.
Medicare Improvements for Patients and Providers Act of 2008
Client: VIATRIS INC · Firm: VIATRIS INC.
S3101/HR6331 Medicare.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree. Authorized Generics
HR2900/S1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree.
HR2900/S1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree. Authorized Generics
S.1145/HR1908 Patent Reform. S316/HR1432 Patent Settlements.
S. 1145 / HR 1908 Patent Reform. S316/HR 1432 Patent Settlements.
Biologics Price Competition and Innovation Act of 2007
Client: VIATRIS INC · Firm: VIATRIS INC.
HR2900/S1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act.
Biologics Price Competition and Innovation Act of 2007
Client: VIATRIS INC · Firm: VIATRIS INC.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree. Authorized Generics
Biologics Price Competition and Innovation Act of 2007
Client: VIATRIS INC · Firm: VIATRIS INC.
HR 2900/S 1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics.
Biologics Price Competition and Innovation Act of 2007
Client: VIATRIS INC · Firm: VIATRIS INC.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree.
Biologics Price Competition and Innovation Act of 2007
Client: VIATRIS INC · Firm: VIATRIS INC.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree.
Biologics Price Competition and Innovation Act of 2007
Client: VIATRIS INC · Firm: VIATRIS INC.
HR2900/S1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics.
Biologics Price Competition and Innovation Act of 2007
Client: VIATRIS INC · Firm: VIATRIS INC.
HR2900/S1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act.
Biologics Price Competition and Innovation Act of 2007
Client: VIATRIS INC · Firm: VIATRIS INC.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree. Authorized Generics
S 1951, The Fair Medicaid Drug Payment Act of 2007, Section 2 (c). FDA drug pedigree issues.
S 1951, the Fair Medicaid Drug Payment Act of 2007, Section 2 (c). FDA Drug pedigree issues.
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5501/S.2731, tom Lantos and Henry J. Hyde United States Global Leasership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/Aids drug treatment.
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5501/S.2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/AIDS drug treatment.
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5501/S.2731, tom Lantos and Henry J. Hyde United States Global Leasership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/Aids drug treatment.
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5501/S.2731, tom Lantos and Henry J. Hyde United States Global Leasership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/Aids drug treatment.
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5501/S.2731, tom Lantos and Henry J. Hyde United States Global Leasership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/Aids drug treatment.
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5501/S.2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/AIDS drug treatment.
Medicare Improvements for Patients and Providers Act of 2008
Client: VIATRIS INC · Firm: VIATRIS INC.
S3101/HR6331 Medicare.
Medicare Improvements for Patients and Providers Act of 2008
Client: VIATRIS INC · Firm: VIATRIS INC.
S3101/HR6331 Medicare.
S.1145/HR1908 Patent Reform. S316/HR1432 Patent Settlements.
S. 1145 / HR 1908 Patent Reform. S316/HR 1432 Patent Settlements.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree. Authorized Generics
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree. Authorized Generics
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree.
PL 111-148 Medicare/Medicaid Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Q4
Patent Settlement and Patent Reform Legislation
HR 1706 Protecting Consumer Access to Generic Drugs Act S 369 Preserve Access to Affordable Generics Act; HR 4899 (sections 4201-4206) regarding drug safety proposal,drug disposal legislation, authorized generics, generic biologics, FDA.
P.L. -111-148, Section 2503
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Q3
Patent Settlement and Patent Reform legislation
H.R. 1706 (Protecting Consumer Access to Generic Drugs Act), S. 369 (Preserve Access to Affordable Drugs Act, H.R. 4899 (Suuplemental Appropriations: Sections 4201-4206). Drug disposal legislation, Food safety Bill and REMS.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Q2
H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); HR 4899 (Supplemental Appropriations: Section 4201-4206)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Q1
H.R. 573, Bill to prohibit authorized generics during period of exclusivity; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Q4
H.R. 573, Bill to prohibit authorized generics during period of exclusivity; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101
PEPFAR
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Q3
PEPFAR
H.R. 573- Bill to prohibit Authorized Generics during exclusivity period, H.R. 1706 - Protecting consumer access to generics drug act, H.R 1427 - Promoting innovation and access to life-saving medicine act, S.369 - Preserve access to affordable generics act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Q2
PEPFAR
Biologics, Pedigree, Authorized Generics, FDA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Q1
Biologics, Foriegn Inspections, Pedigree, Authorized Generics
PEPFAR
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · 4A
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree. Authorized Generics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · 3A
S3101/HR6331 Medicare.
H.R. 5501/S.2731, tom Lantos and Henry J. Hyde United States Global Leasership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/Aids drug treatment.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · 2A
H.R. 5501/S.2731, tom Lantos and Henry J. Hyde United States Global Leasership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/Aids drug treatment.
HR2900/S1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · 1A
S. 1145 / HR 1908 Patent Reform. S316/HR 1432 Patent Settlements.
H.R. 5501/S.2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/AIDS drug treatment.
US Customs and Border Protection.
2008 · fourth_quarter · Q4
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree. Authorized Generics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Q3
S3101/HR6331 Medicare.
S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act. S3409 Foriegn Inspections. HR 5839 Pedigree.
H.R. 5501/S.2731, tom Lantos and Henry J. Hyde United States Global Leasership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/Aids drug treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Q2
H.R. 5501/S.2731, tom Lantos and Henry J. Hyde United States Global Leasership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/Aids drug treatment.
HR2900/S1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics. HR6344 Responsive Government Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Q1
S.1145/HR1908 Patent Reform. S316/HR1432 Patent Settlements.
HR2900/S1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics.
US Customs and Border Protection
2007 · year_end · YY
- Issues regarding PEPFAR
- Issues regarding Medicaid Rebates and Authorized Generics
- Issues regarding Hatch-Waxman reform - General Patent Issues - Patent Reform
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2007 · mid_year · MM
- Issues regarding Hatch-Waxman reform - General Patent issues
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2006 · year_end · YY
- Issues regarding Hatch-Waxman reform - General Patent issues
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2006 · mid_year · MM
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2006 · year_end · YY
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2006 · year_end · YY
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S 1951, the Fair Medicaid Drug Payment Act of 2007, Section 2 (c). FDA Drug pedigree issues.
HR 2900/S 1082 Citizen Petitions. S1695/HR5629/HR1038 Biologics.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
S 1951, The Fair Medicaid Drug Payment Act of 2007, Section 2 (c). FDA drug pedigree issues.
H.R. 5501/S.2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/Aids, and Malaria Reauthorization Act of 2008, Provisions pertaining to HIV/AIDS drug treatment.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE